Rubin David T, Traboulsi Cindy, Rai Victoria
University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois.
Gastroenterol Hepatol (N Y). 2021 Feb;17(2):59-66.
Patients with ulcerative colitis (UC) can experience periods of recurrent disease activity with a range of symptoms, including abdominal pain, rectal bleeding, urgency, and diarrhea. Although long-term remission will be achieved and maintained in most cases, the course of UC varies from patient to patient. Patients can be defined according to whether they are in remission or have mild, moderate, severe, or fulminant disease, and hospitalization can occur under different circumstances. In these cases, determining the next course of therapy is essential. The aim of this article is to present an approach to the treatment of high-risk UC in both the outpatient and inpatient settings. Also presented is a critical appraisal of alternative and emerging approaches to the management of patients with high-risk UC. Fundamental principles are key in the management of high-risk UC, including discussing the goals of treatment with the patient and family, assessing each patient's risk level and prognostic factors in addition to disease activity to inform therapeutic choices, understanding drug mechanisms and pharmacokinetics, and using objective measures to monitor disease response. In the treatment of all patients with high-risk UC, a balanced approach to deciding between medical and surgical options must be maintained.
溃疡性结肠炎(UC)患者可能会经历疾病复发期,出现一系列症状,包括腹痛、直肠出血、便急和腹泻。尽管大多数情况下能实现并维持长期缓解,但UC的病程因患者而异。患者可根据处于缓解期、患有轻度、中度、重度或暴发性疾病来定义,且在不同情况下可能需要住院治疗。在这些情况下,确定下一步治疗方案至关重要。本文旨在介绍门诊和住院环境下高危UC的治疗方法。同时还对高危UC患者管理的替代方法和新兴方法进行了批判性评估。基本原则是高危UC管理的关键,包括与患者及其家属讨论治疗目标、除疾病活动外评估每位患者的风险水平和预后因素以指导治疗选择、了解药物机制和药代动力学,以及使用客观指标监测疾病反应。在所有高危UC患者的治疗中, 必须在医疗和手术选择之间保持平衡的决策方法。